Dihydroorotate dehydrogenase
Dihydroorotate dehydrogenase
Dihydroorotate dehydrogenase (DHODH) is an enzyme that plays a crucial role in the de novo synthesis of pyrimidines. It catalyzes the fourth step in the pyrimidine biosynthesis pathway, which is the conversion of dihydroorotate to orotate. This reaction is essential for the production of uridine monophosphate (UMP), a precursor for all pyrimidine nucleotides.
Function[edit | edit source]
DHODH is a flavoprotein that uses flavin mononucleotide (FMN) as a cofactor. The enzyme is located in the inner mitochondrial membrane in eukaryotes and in the cytoplasm of prokaryotes. The reaction catalyzed by DHODH involves the oxidation of dihydroorotate to orotate, with the concomitant reduction of quinone to quinol in eukaryotes or the reduction of NAD+ to NADH in prokaryotes.
Structure[edit | edit source]
The structure of DHODH varies between species. In humans, DHODH is a monomeric enzyme composed of a single polypeptide chain. The active site of the enzyme contains a binding pocket for dihydroorotate and FMN. The enzyme also has a hydrophobic domain that anchors it to the inner mitochondrial membrane.
Clinical Significance[edit | edit source]
DHODH is a target for several immunosuppressive and antiproliferative drugs. Inhibitors of DHODH, such as leflunomide and teriflunomide, are used in the treatment of rheumatoid arthritis and multiple sclerosis, respectively. These drugs work by depleting pyrimidine pools, which inhibits the proliferation of rapidly dividing cells, including lymphocytes.
Genetic Disorders[edit | edit source]
Mutations in the DHODH gene can lead to Miller syndrome, a rare genetic disorder characterized by craniofacial abnormalities and limb defects. This condition is inherited in an autosomal recessive manner.
Research Applications[edit | edit source]
DHODH is studied extensively in the context of cancer and infectious diseases. Inhibitors of DHODH are being investigated as potential treatments for various types of cancer, as well as for malaria and viral infections.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD